Our Team

Timesulin is a brand of Patients Pending Ltd, established in 2010 to create unique and patentable solutions to daily issues faced by people living with chronic conditions. We focus on simplicity for the user for every design decision we make. Our first patented product, Timesulin, has achieved international adoption by the diabetes community globally through partnerships with diabetes patient associations, relationships with large pharmaceutical companies and direct sales to customers who can benefit from the security that Timesulin provides.

Timesulin Team

  • John Sjolund
    John Sjolund CEO & Co-Founder
  • Ilke De Gouveia
    Ilke De Gouveia Finance Director
  • Andreas Sjolund
    Andreas Sjolund Board Member & Co-Founder
  • Per Olof Wallström
    Per Olof Wallström Advisor
  • Claudio Carboni
    Claudio Carboni Director & Board Member
  • Erik Sundquist
    Erik Sundquist Senior Advisor APAC

Timesulin Advisors

The Timesulin team is compromised of a global network of partners, consultants and advisors.

  • Paul Madden
    Paul Madden Senior Healthcare Executive
  • Gunnar Wormbs
    Gunnar Wormbs Director of Operational Excellence at GE Healthcare
  • Max Sakajja
    Max Sakajja Business Development & Strategy at Envirotainer
  • Eric Tizioni
    Eric Tizioni Business Development Leader at GE Healthcare

Get To Know Us

Timesulin Addresses

United Kingdom

Patients Pending Ltd
145 – 157 St John Street
London EC1V 4PY
United Kingdom

Phone: 0200 333 1879


Patients Pending AB
Stureplan 6
114 35 Stockholm

Phone: 08-559 21 224